Former FDA chief Scott Gottlieb on Trump's decision to take hydroxychloroquine

President Donald Trump said Monday that he has been taking anti-malaria drug hydroxychloroquine for over a week to prevent coronavirus infection even though it is not yet a proven treatment. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, weighs in on President Trump's decision and what medical experts know about the effectiveness of the drug.
Tue, May 19 20207:25 AM EST